Severity of Plasma Leakage Is Associated With High Levels of Interferon γ–Inducible Protein 10, Hepatocyte Growth Factor, Matrix Metalloproteinase 2 (MMP-2), and MMP-9 During Dengue Virus Infection

Journal of Infectious Diseases

Volumn 215, Issue 1, 2017, Pages 42-51

  Her, Zhisheng ^a   Kam, Yiu Wing ^a   Gan, Victor C ^b   Lee, Bernett ^a   Thein, Tun Linn ^b   Tan, Jeslin J L ^a   Lee, Linda K ^b   Fink, Katja ^a   Lye, David C ^b   Rénia, Laurent ^a   Leo, Yee Sin ^b,c   Ng, Lisa F P ^a,d   Nardin, Alessandra ^e   Larbi, Anis ^e   Poidinger, Michael ^e   Abel, Brian ^e   Hasse, Doreen ^e   Au, Veonice ^e   Wing Hei, Esther Mok ^e   Tang, Suisheng ^e   Chou Yue, Joni Chong ^e   more..

^a AGENCY FOR SCIENCE   (Singapore)

^b TAN TOCK SENG HOSPITAL   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

^e NONE

Author keywords

cytokines; dengue virus; plasma leakage

Indexed keywords

COLLAGENASE 3; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GELATINASE A; GELATINASE B; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; INTERLEUKIN 9; INTERSTITIAL COLLAGENASE; MACROPHAGE ELASTASE; MACROPHAGE MIGRATION INHIBITION FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR BB; RANTES; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; CXCL10 PROTEIN, HUMAN; CYTOKINE; HGF PROTEIN, HUMAN; IL1RN PROTEIN, HUMAN; MATRIX METALLOPROTEINASE; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; APOPTOSIS; ARTICLE; CYTOKINE RELEASE; DENGUE; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNOASSAY; IMMUNOMODULATION; LIMIT OF DETECTION; MACROPHAGE MIGRATION; MAJOR CLINICAL STUDY; MALE; PLASMA; PLASMA LEAKAGE; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; PROTEIN EXPRESSION; SINGAPORE; BLOOD; CAPILLARY PERMEABILITY; DENGUE VIRUS; IMMUNOLOGY; MIDDLE AGED; MIXED INFECTION; PATHOGENICITY; PATHOPHYSIOLOGY; PHYSIOLOGY; SEROTYPE; SEVERE DENGUE; VIROLOGY;

ADULT; CAPILLARY PERMEABILITY; CHEMOKINE CXCL10; COINFECTION; CYTOKINES; DENGUE; DENGUE VIRUS; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; SEROGROUP; SEVERE DENGUE; SINGAPORE; VASCULAR CELL ADHESION MOLECULE-1;

EID: 85028444048     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/INFDIS/JIW494     Document Type: Article

References (43)

1. World Health Organization (WHO). Dengue guidelines for diagnosis, treatment, prevention and control: new edition. Geneva: World Health Organization 2009.
2. Bhatt S, Gething PW, Brady OJ, et al. The global distribution and burden of dengue. Nature 2013; 496:504–7.
3. Nimmannitya S. Clinical spectrum and management of dengue haemorrhagic fever. Southeast Asian J Trop Med Public Health 1987; 18:392–7.
4. Rothman AL, Srikiatkhachorn A, Green S. Markers of Dengue disease severity. Curr Top Microbiol Immunol 2010; 338:67–82.
5. Martina BE, Koraka P, Osterhaus AD. Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev 2009; 22:564–81.
6. Choudhury J, Shastri DD. Diagnosis and management of dengue in children: Recommendations and IAP ID chapter plan of action. Ped Infect Dis 2014; 6:54–62.
7. Mathew A, Rothman AL. Understanding the contribution of cellular immunity to dengue disease pathogenesis. Immunol Rev 2008; 225:300–13.
8. Chaturvedi UC, Agarwal R, Elbishbishi EA, Mustafa AS. Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis. FEMS Immunol Med Microbiol 2000; 28:183–8.
9. Luplerdlop N, Missé D, Bray D, et al. Dengue-virus-infected dendritic cells trigger vascular leakage through metalloproteinase overproduction. EMBO Rep 2006; 7:1176–81.
10. Luplertlop N, Missé D. MMP cellular responses to dengue virus infection-induced vascular leakage. Jpn J Infect Dis 2008; 61:298–301.
11. Basu A, Chaturvedi UC. Vascular endothelium: the battlefield of Dengue viruses. FEMS Immunol Med Microbiol 2008; 53:287–99.
12. Wong JGX, Gan VC, Ng EL, et al. Self-reported pain intensity with the numeric reporting scale in adult Dengue. PLoS One 2014; 9:e96514.
13. Gan VC, Tan LK, Lye DC, et al. Diagnosing dengue at the point-of-care: utility of a rapid combined diagnostic kit in Singapore. PLoS One 2014; 9:e90037.
14. Saeed AI, Sharov V, White J, et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 2003; 34:374–8.
15. Rathakrishnan A, Wang SM, Hu Y, et al. Cytokine expression profile of dengue patients at different phases of illness. PLoS One 2012; 7:e52215.
16. Nimmannitya S, Halstead SB, Cohen SN, Margiotta MR. Dengue and Chikungunya virus infection in man in Thailand, 1962–1964: I. Observations on hospitalized patients with hemorrhagic fever. Am J Trop Med Hyg 1969; 18:954–71.
17. Michels M, Alisjahbana B, De Groot PG, et al. Platelet function alterations in dengue are associated with plasma leakage. Thromb Haemost 2014; 112:352–62.
18. Nagase H, Woessner JF. Matrix metalloproteinases. J Biol Chem 1999; 274:21491–4.
19. Voraphani N, Khongphatthanayothin A, Srikaew K, Tontulawat P, Poovorawan Y. Matrix metalloproteinase-9 (mmp-9) in children with dengue virus infection. Jpn J Infect Dis 2010; 63:346–8.
20. Luplerdlop N, Missé D. MMP cellular response to Dengue virus infection-induced vascular leakage. Jpn J Infect Dis 2008; 61:298–301.
21. Chen RF, Yang KD, Wang L, Liu JW, Chiu CC, Cheng JT. Different clinical and laboratory manifestations between dengue haemorrhagic fever and dengue fever with bleeding tendency. Trans R Soc Trop Med Hyg 2007; 101:1106–13.
22. Guzman M, Alvarez M, Halstead S. Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection. Arch Virol 2013; 158:1445–59.
23. Anantapreecha S, Chanama S, A-nuegoonpipat A, et al. Serological and virological features of dengue fever and dengue haemorrhagic fever in Thailand from 1999 to 2002. Epidemiol Infect 2005; 133:503–7.
24. Bhamarapravati N, Tuchinda P, Boonyapaknavik V. Pathology of Thailand haemorrhagic fever: a study of 100 autopsy cases. Ann Trop Med Parasitol 1967; 61:500–10.
25. Avirutnan P, Malasit P, Seliger B, Bhakdi S, Husmann M. Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J Immunol 1998; 161:6338–46.
26. Appanna R, Wang SM, Ponnampalavanar SA, Lum LCS, Sekaran SD. Cytokine factors present in Dengue patient sera induces alterations of junctional proteins in human endothelial cells. Am J. Trop Med Hyg 2012; 87:936–42.
27. Rothman AL, Ennis FA. Immunopathogenesis of Dengue hemorrhagic fever. Virology 1999; 257:1–6.
28. Brown MG, Hermann LL, Issekutz AC, et al. Dengue virus infection of mast cells triggers endothelial cell activation. J Virol 2010; 85:1145–50.
29. Koraka P, Murgue B, Deparis X, et al. Elevation of soluble VCAM-1 plasma levels in children with acute dengue virus infection of varying severity. J Med Virol 2004; 72:445–50.
30. Voraphani N, Theamboonlers A, Khongphatthanayothin A, Srisai C, Poovorawan Y. Increased level of hepatocyte growth factor in children with dengue virus infection. Ann Trop Paediatr 2010; 30:213–8.
31. Tseng CS, Lo HW, Teng HC, Lo WC, Ker CG. Elevated levels of plasma VEGF in patients with dengue hemorrhagic fever. FEMS Immunol Med Microbiol 2005; 43:99–102.
32. Huang YH, Lei HY, Liu HS, Lin YS, Liu CC, Yeh TM. Dengue virus infects human endothelial cells and induces IL-6 and IL-8 production. Am J Trop Med Hyg 2000; 63:71–5.
33. Butthep P, Chunhakan S, Yoksan S, Tangnararatchakit K, Chuansumrit A. Alteration of cytokines and chemokines during febrile episodes associated with endothelial cell damage and plasma leakage in Dengue hemorrhagic fever. Pediatr Infect Dis J 2012; 31:e232–8.
34. Moi ML, Takasaki T, Saijo M, Kurane I. Dengue virus infection-enhancing activity of undiluted sera obtained from patients with secondary dengue virus infection. Trans R Soc Trop Med Hyg 2013; 107:51–8.
35. Halstead SB. Neutralization and antibody-dependent enhancement of dengue viruses. Adv Virus Res 2003; 60:421–67.
36. Yeo AS, Azhar NA, Yeow W, et al. Lack of clinical manifestations in asymptomatic dengue infection is attributed to broad down-regulation and selective up-regulation of host defence response genes. PLoS One 2014; 9:e92240.
37. Itoh T, Matsuda H, Tanioka M, Kuwabara K, Itohara S, Suzuki R. The role of matrix metalloproteinase-2 and matrix metalloproteinase-9 in antibody-induced arthritis. J Immunol 2002; 169:2643–7.
38. Longo GM, Xiong W, Greiner TC, Zhao Y, Fiotti N, Baxter BT. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest 2002; 110:625–32.
39. Lambert V, Wielockx B, Munaut C, et al. MMP-2 and MMP-9 synergize in promoting choroidal neovascularization. FASEB J 2003; 17:2290–2.
40. Masson V, de la Ballina LR, Munaut C, et al. Contribution of host MMP-2 and MMP-9 to promote tumor vascularization and invasion of malignant keratinocytes. FASEB J 2005; 19:234–6.
41. Chipwaza B, Mugasa JP, Selemani M, et al. Dengue and Chikungunya fever among viral diseases in outpatient febrile children in Kilosa district hospital, Tanzania. PLoS Negl Trop Dis 2014; 8:e3335.
42. Kenah E, Chao DL, Matrajt L, Halloran ME, Longini IM Jr. The global transmission and control of influenza. PLoS One 2011; 6:e19515.
43. Teng TS, Kam YW, Lee B, et al. A systematic meta-analysis of immune signatures in patients with acute chikungunya virus infection. J Infect Dis 2015; 211:1925–35.